JPS57114513A - Drug against arterioscleriosis comprising (3-dimethylca- rbamoxyphenyl)trimethyl ammonium derivative - Google Patents

Drug against arterioscleriosis comprising (3-dimethylca- rbamoxyphenyl)trimethyl ammonium derivative

Info

Publication number
JPS57114513A
JPS57114513A JP18401381A JP18401381A JPS57114513A JP S57114513 A JPS57114513 A JP S57114513A JP 18401381 A JP18401381 A JP 18401381A JP 18401381 A JP18401381 A JP 18401381A JP S57114513 A JPS57114513 A JP S57114513A
Authority
JP
Japan
Prior art keywords
trimethyl ammonium
drug against
rbamoxyphenyl
arterioscleriosis
dimethylca
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP18401381A
Other languages
Japanese (ja)
Other versions
JPS5751810B2 (en
Inventor
Ayanori Takabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP18401381A priority Critical patent/JPS57114513A/en
Publication of JPS57114513A publication Critical patent/JPS57114513A/en
Publication of JPS5751810B2 publication Critical patent/JPS5751810B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: A drug against arterioschleriosis having low side effects even by long- term medication, comprising a (3-dimethylcarbamoxyphenyl)trimethyl ammonium as an active ingredient.
CONSTITUTION: The titled agent comprising a well-known compound shown by the formula (R is methylsulfuric group or Br) of a parasympathetic analeptic as an active ingredient. The agent is medicated orally or parenterally in the form of powder, talbet, suppository, injection, etc. to man and animals, and oral administration is preferable. Preferably, a human oral dose is 0.1W50mg/kg/day, and its parenteral dose is 0.001W0.1mg/kg/day, medicated oneW divided four times.
COPYRIGHT: (C)1982,JPO&Japio
JP18401381A 1981-11-17 1981-11-17 Drug against arterioscleriosis comprising (3-dimethylca- rbamoxyphenyl)trimethyl ammonium derivative Granted JPS57114513A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18401381A JPS57114513A (en) 1981-11-17 1981-11-17 Drug against arterioscleriosis comprising (3-dimethylca- rbamoxyphenyl)trimethyl ammonium derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18401381A JPS57114513A (en) 1981-11-17 1981-11-17 Drug against arterioscleriosis comprising (3-dimethylca- rbamoxyphenyl)trimethyl ammonium derivative

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP1989380A Division JPS56115715A (en) 1980-02-20 1980-02-20 Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative

Publications (2)

Publication Number Publication Date
JPS57114513A true JPS57114513A (en) 1982-07-16
JPS5751810B2 JPS5751810B2 (en) 1982-11-04

Family

ID=16145800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18401381A Granted JPS57114513A (en) 1981-11-17 1981-11-17 Drug against arterioscleriosis comprising (3-dimethylca- rbamoxyphenyl)trimethyl ammonium derivative

Country Status (1)

Country Link
JP (1) JPS57114513A (en)

Also Published As

Publication number Publication date
JPS5751810B2 (en) 1982-11-04

Similar Documents

Publication Publication Date Title
JPS5551020A (en) Remedy for rheumatism
JPS5767516A (en) Novel analgesic agent
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS5630917A (en) Preventive and remedy for hepatitis
JPS57114513A (en) Drug against arterioscleriosis comprising (3-dimethylca- rbamoxyphenyl)trimethyl ammonium derivative
JPS57114514A (en) Antiphlogistic comprising (3-dimethylcarbamoxyphenyl) trimethyl ammonium derivative
JPS57114515A (en) Antipyr eticand analgesic comprising (3-dimethylcarbam- oxyphenyl)trimethyl ammonium derivative
JPS54132239A (en) Anti-tumor agent
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
ES8602654A1 (en) Medicines based on piperidine derivatives, piperidine derivatives and process for their preparation.
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS57128625A (en) Carcinostatic
JPS57114519A (en) Antiarteriosclerotic agent
JPS5731616A (en) Relaxing agent for muscle comprising benzofurancarboxylic acid amide
JPS5536454A (en) Novel immunosuppressive agent
JPS5569510A (en) Carcinostatic agent
JPS5498339A (en) Carcinostatic agent
JPS643120A (en) Drug composition having inhibitory action on encephalopathy
JPS57114520A (en) Antiarteriosclerotic agent
JPS57144216A (en) Antiulcer
JPS57126422A (en) Stabilizing method of lysozyme pharmaceutical
JPS5759809A (en) Cardiotonic agent
JPS5675427A (en) Antiarteriosclerotic agent containing procainamide hydrochloride
JPS57112327A (en) Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid
JPS5634625A (en) Antitumorigenic agent